ANN SURG ONCOL 润色咨询

ANNALS OF SURGICAL ONCOLOGY

出版年份:1994 年文章数:9919 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
50.0元/篇 (网友贡献,非官方数据)
版面费用
100.0元/篇 (网友贡献,非官方数据)
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
6.8 %
年文章数
9919
期刊官网
点击查看 (点击次数:16231)
点击查看 (点击次数:9297次)
作者需知
点击查看 (点击次数:1831次)
期刊简介
稿件收录要求
Annals of Surgical Oncology is specifically designed to bring the latest, most significant developments involving multidisciplinary cancer care and research to the practicing surgeon from all specialties. Each issue features original articles on multidisciplinary cancer care, surgical care of the cancer patient, and results of clinically-relevant cancer research; mini-courses and symposia related to multidisciplinary management of surgical patients with cancer; and educational reviews about basic science advances, advances in surgery, adjuvant therapies, cancer prevention, rehabilitation, and socioeconomic issues involving the cancer patient.

The Annals of Surgical Oncology (ASO) promotes high-quality surgical oncology management by communicating advances in research and education that are relevant and valuable to the provision of contemporary multidisciplinary care for patients with cancer.

The official journal of the Society of Surgical Oncology (SSO) and the American Society of Breast Surgeons, ASO is the journal of choice of surgical oncologists worldwide regarding surgical oncology research and education.

The mission of the Annals of Surgical Oncology is to serve its readers by 1) representing and advancing the profession of surgical oncology throughout the nation and the world; 2) promoting the highest quality multidisciplinary patient care and practice management; 3) providing relevant cancer education and research training materials using print and electronic media; 4) promoting clinical and translational cancer research, with an emphasis on clinical trials; 5) facilitating the career development of surgical trainees and their transition into academic and community-based practice; and 6) promoting public policy and patient advocacy issues related to surgical patient with cancer.